Results 111 to 120 of about 16,398 (301)

Guía de práctica clínica sobre la prevención primaria y secundaria del ictus

open access: yes
Ictus; Prevenció; Medicina basada en l'evidènciaPrevention; Evidence-based medicinePrevención; Medicina basada en la evidenciaEsta guía se ha desarrollado con los siguientes objetivos: ofrecer recomendaciones al profesional para mejorar la atención a los
Grupo de Trabajo de la GPC sobre la Prevención Primaria y Secundaria del Ictus
core  

Utility of the APE2 Score as a Diagnostic Tool for Autoimmune Encephalitis

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To retrospectively evaluate the diagnostic performance of the Antibody Prevalence in Epilepsy and Encephalopathy (APE2) score relative to clinician‐adjudicated autoimmune encephalitis (AE) and the Graus criteria in a tertiary neuroimmunology referral cohort, including antibody‐negative AE.
Bijoya Basu   +3 more
wiley   +1 more source

Registro prospectivo de ictus intrahospitalarios [PDF]

open access: yes, 2012
Antecedentes: Los ictus intrahospitalarios (IIH) son frecuentes, suponen entre el 4.4 y el 15% del total de ictus. Tienen mayor gravedad y peor pronóstico.
Vera Lechuga, Rocío
core   +2 more sources

C?digo ictus

open access: yes, 2018
El ictus es una emergencia neurol?gica. Los estudios y conocimientos que se tienen acerca del mismo han podido determinar que una vez que se produce la hemorragia o isquemia cerebral su progresi?n es muy r?pida. Por ello, la aplicaci?n del tratamiento adecuado en ese breve margen de actuaci?n resulta esencial. Mediante la protocolizaci?n y organizaci?n
openaire   +1 more source

Temporal Divergence of True and False Alarms in Pediatric Nocturnal Seizure Monitoring

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
The early‐morning surge in false seizure alarms supports exploring time‐ or state‐dependent detection thresholds to reduce false detections. ABSTRACT Seizure detection devices can improve the safety of children with epilepsy, yet high false alarms limit their clinical applicability.
Mohammad Shahbakhti   +6 more
wiley   +1 more source

ICTUS

open access: yes, 2018
Según la OMS, se registran al año 6,7 millones de muertes que son causadas por accidentes cerebrovasculares; por lo que instituciones como Valle del Lili implementan estrategias para disminuir la mortalidad por esta causa. El doctor Pablo Amaya, con ayuda de neurólogos, neurocirujanos, neuro-radiologos, terapeutas endovasculares y especialistas en ...
openaire   +1 more source

Early Clinical and Cerebrospinal Fluid Predictors of 1‐Year Recurrence in Autoimmune GFAP Astrocytopathy

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Autoimmune glial fibrillary acidic protein astrocytopathy (GFAP‐A) is an inflammatory central nervous system disorder with variable outcomes. Relapse occurs in a subset of patients, but early predictors remain unclear. We aimed to identify admission‐available features associated with 1‐year recurrence and develop an interpretable ...
Qingting Hong   +10 more
wiley   +1 more source

A Novel KCNA1 Variant in a Patient With Tremor and Autism Spectrum Disorder Causes Mixed LOF/GOF Defects of Kv1.1 Channels

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Variants in KCNA1, encoding the Kv1.1 potassium channel, cause neurological disorders including episodic ataxia and developmental and epileptic encephalopathy. We identified a novel KCNA1 variant (A401T) in a 16‐year‐old patient with autism spectrum disorder, borderline intellectual disability, and tremor, without episodic ataxia or epilepsy ...
Juan Darío Ortigoza‐Escobar   +7 more
wiley   +1 more source

Ofatumumab Therapy and Long‐Term Seizure Outcomes of Patients With Relapsing Anti‐NMDA Receptor Encephalitis

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective There is a lack of studies on seizure outcomes associated with ofatumumab therapy in patients for relapsing anti‐N‐methyl‐D‐aspartate (NMDA) receptor encephalitis. We aimed to evaluate long‐term seizure outcomes of ofatumumab therapy for relapsing anti‐NMDA receptor encephalitis.
Jian Wang, Mengjiao Li, Ping Kong
wiley   +1 more source

Home - About - Disclaimer - Privacy